Aurora Cannabis Continues To Grow Like A Weed

Aurora Cannabis Inc. (ACB.TO) (ACBFF) continues to execute and advance its business model as Canada prepares to legalize recreational cannabis and the market has taken notice of this.

For the second time in ten days, Canaccord Genuity raised its price target on the Canadian medical marijuana producer. Today, Canaccord raised its price target on Aurora to $4.45 from $3.65 (on November 2nd, Canaccord raised it to $3.65 from $3.25).

Emerald Health Pharmaceuticals Granted FDA Orphan Drug Designation for Systemic Scleroderma

Emerald Health Pharmaceuticals Inc. (EHP), which is developing medications based on cannabinoid science, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead molecule, EHP-101, for the treatment of systemic scleroderma. This chronic autoimmune disease causes severe fibrosis of the skin and internal organs and is associated with significant morbidity and mortality.

Earnings to Expansion: 3 Canadian Pot Stocks to Watch

From quarterly earnings to production capacity expansions, Canadian cannabis companies continue to execute and work toward delivering value to its shareholder.

Although companies levered to this burgeoning opportunity have been under significant pressure, we believe the industry is nearing a bottom and this will create several opportunities for strategic investors.

Brad Trost Wants to Kill Legal Canadian Cannabis

Brad Trost, a Conservative leadership candidate who says he does not believe climate change, opposes transgender rights, gay marriage and abortion, has a new target…cannabis

Trost has sponsored a petition to repeal the Cannabis Act which was submitted to the House of Commons last month. The petition opened on May 8th and has less than 1,500 signatures but this guys must be stopped in his tracks.

WeedMD Commences Trading

WeedMD Inc. came roaring out of the gates yesterday when it commenced trading on the TSX Venture Exchange under the symbol WMD.V.

WeedMD is a licensed producer of medical cannabis under the ACMPR and plans to be Canada’s first producer focused on the long-term and retirement sector by leveraging its deep industry relationships and expertise.

Trump Tweets Triggering a Canadian Sell Off?

Despite the Dow rallying another 220 points and the Nasdaq ending the day above the 6,000, Canadian cannabis stocks were under pressure.

This pressure accelerated throughout the day and followed this tweet from President Trump, “Canada has made business for our dairy farmers in Wisconsin and other border states very difficult. We will not stand for this. Watch!”

5 Must Read Canadian Cannabis Stock Updates

Canadian stocks levered to the emerging cannabis industry have been on watch after the Canadian Federal government tabled the Cannabis Act last week.

This legislation will create a legal recreational cannabis market in Canada before July 1, 2018. Following the introduction of the Cannabis Act, the market has seen series of significant company developments as these companies work to put themselves in a position to capitalize on this multi-billion-dollar opportunity.